http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#Head http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#provenance http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#pubinfo http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion http://purl.obolibrary.org/obo/DOID_0060329 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0060329 http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00834 http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association http://www.w3.org/2000/01/rdf-schema#label "Administration of Mifepristone tablets, 200mg and misoprostol for the termination of pregnancy (the ""treatment procedure"") is contraindicated in patients with any of the following conditions: - [ see Warnings and Precautions ( 5.4 - - - [ see Adverse Reactions ( 6.2 - - Use of Mifepristone tablets, 200mg and misoprostol for termination of intrauterine pregnancy is contraindicated in patients with an intrauterine device (""IUD"") in place (the IUD might interfere with pregnancy termination). If the IUD is removed, Mifepristone tablets, 200mg may be used. Confirmed/suspected ectopic pregnancy or undiagnosed adnexal mass ( 4 Chronic adrenal failure ( 4 Concurrent long-term corticosteroid therapy ( 4 History of allergy to mifepristone, misoprostol, or other prostaglandins ( 4 Hemorrhagic disorders or concurrent anticoagulant therapy ( 4 Inherited porphyria ( 4 Intrauterine device (IUD) in place ( 4" http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00834 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#provenance http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#pubinfo http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig http://purl.org/nanopub/x/hasSignature MiJ2d8T4YM9Y5+vTXmHhiiKj9zjGrZxCttC/tM/FIaR+nL5pgqXz7ZTr4wQXbLa2ZSpXbXqZMiNGEpUu/ucjae/g4xS1Ay5Vn+HGhO/25vgnncizGdcUY3QYfFU+lhcUXPWSlPHc8MFRPrqdBSy871NgSRP1U+ALAA1DAeQR6FA= http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://purl.org/dc/terms/created 2021-08-23T18:41:12.827+02:00 http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY